BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27645518)

  • 41. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
    Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
    Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cost of early management of chronic inflammatory intestinal disease].
    Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
    Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016).
    Ma C; Smith MK; Guizzetti L; Panaccione R; Kaplan GG; Novak KL; Lu C; Khanna R; Feagan BG; Singh S; Jairath V; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2500-2509.e1. PubMed ID: 31988046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review.
    El-Matary W; Kuenzig ME; Singh H; Okoli G; Moghareh M; Kumar H; LĂȘ ML; Benchimol EI
    Inflamm Bowel Dis; 2020 Jan; 26(2):206-215. PubMed ID: 31211827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change.
    van Langenberg DR; Lange K; Hetzel DJ; Holtmann GJ; Andrews JM
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1250-8. PubMed ID: 20594252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease.
    Blaney H; Vu P; Mathew A; Snelling R; England J; Duong C; Hammonds K; Johnson C
    Dig Dis Sci; 2021 Aug; 66(8):2555-2563. PubMed ID: 32892260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease.
    Gan RW; Sun D; Tatro AR; Cohen-Mekelburg S; Wiitala WL; Zhu J; Waljee AK
    PLoS One; 2021; 16(9):e0257520. PubMed ID: 34543353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and lifetime risk of endoscopy-related complications among patients with inflammatory bowel disease.
    Ferreira J; Akbari M; Gashin L; Cullen G; Moss A; Leffler DA; Aronson M; Cheifetz AS
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1288-93. PubMed ID: 23669305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States: 1994-2005.
    Ananthakrishnan AN; McGinley EL; Saeian K; Binion DG
    Am J Gastroenterol; 2010 Feb; 105(2):363-70. PubMed ID: 19809414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.
    Alley K; Singla A; Afzali A
    Inflamm Bowel Dis; 2019 Nov; 25(12):1990-1995. PubMed ID: 31087042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for 90-day readmission in veterans with inflammatory bowel disease-Does post-discharge follow-up matter?
    Malhotra A; Phatharacharukul P; Thongprayoon C
    Mil Med Res; 2018 Feb; 5(1):5. PubMed ID: 29502532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence.
    Santiago M; Magro F; Correia L; Portela F; Ministro P; Lago P; Trindade E; Dias CC
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00227. PubMed ID: 33094955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physician density and hospitalization for inflammatory bowel disease.
    Ananthakrishnan AN; McGinley EL; Binion DG; Saeian K
    Inflamm Bowel Dis; 2011 Feb; 17(2):633-8. PubMed ID: 20848540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Report: economic implications of inflammatory bowel disease and its management.
    Mehta F
    Am J Manag Care; 2016 Mar; 22(3 Suppl):s51-60. PubMed ID: 27269903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada.
    Dheri AK; Kuenzig ME; Mack DR; Murthy SK; Kaplan GG; Donelle J; Smith G; Benchimol EI
    J Crohns Colitis; 2021 Dec; 15(12):1991-2000. PubMed ID: 34019625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Descriptive epidemiology of children hospitalized for inflammatory bowel disease in Japan: Inpatient database analysis.
    Takeuchi M; Tomomasa T; Yasunaga H; Horiguchi H; Fushimi K
    Pediatr Int; 2015 Jun; 57(3):443-8. PubMed ID: 25442802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disability in Restorative Proctocolectomy Recipients Measured using the Inflammatory Bowel Disease Disability Index.
    Lee Y; McCombie A; Gearry R; Frizelle FA; Vanamala R; Leong RW; Eglinton T
    J Crohns Colitis; 2016 Dec; 10(12):1378-1384. PubMed ID: 27282401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study.
    Tse CS; Siegel CA; Weaver SA; Oliver BJ; Bresee C; van Deen WK; Melmed GY
    Inflamm Bowel Dis; 2022 Oct; 28(10):1565-1572. PubMed ID: 34893849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.